Skip to main content
Premium Trial:

Request an Annual Quote

Parts of Ex-CFO's Lawsuit Against Sequenom Thrown Out

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A California court has struck down part of a lawsuit filed by Sequenom's former chief financial officer's lawsuit against the company and three of its former executives and directors, the San Diego-based molecular diagnostics firm said last week.

In a document filed with the US Securities and Exchange Commission, Sequenom said that on Jan. 5, the Superior Court of California for the County of San Diego informed it that the court has granted motions by Sequenom and individual defendants against a lawsuit filed by Paul Hawran during the summer.

The court has removed claims by Hawran alleging "negligent and intentional misrepresentation and negligent and intentional interference with prospective economic advantage" by Sequenom and the individual defendants in the case, current Chairman and CEO Harry Hixson, senior vice president of R&D Ronald Lindsay, and Richard Lerner, a director at the company.

Sequenom added that Hawran's claim against the individual defendants alleging breach of contract was also removed by the court. His allegations that Sequenom breached his contract and his claim of defamation, invasion of privacy, and unfair business practices by the company and the individual defendants remain, however.

Hawran resigned from Sequenom in 2009 as a result of an investigation into mishandled R&D test data in Sequenom's Down syndrome molecular diagnostic program. Along with Hawran's resignation, Harry Stylli, the president and CEO of Sequenom at the time, was fired as a result.

In his lawsuit, Hawran alleged he was asked to resign because of concerns he had raised about the conduct of certain Sequenom directors.

In its SEC document, Sequenom said that the court has denied it and the individual defendants' demurrer. Sequenom and they plan to "vigorously defend ourselves against the remaining claims," the company said.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.